TERT-BUTYL (2R,3S)-3-HYDROXY-2-METHYLAZETIDINE-1-CARBOXYLATE, 95%, 100mg

2-(4-Isopropoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

N-(5-METHYL-2-OXO-2,3-DIHYDROPYRIMIDIN-4-YL)BENZAMIDE, 95.0%, 1g

Ethyl 2-phenylpyrimidine-5-carboxylate, 95.0%, 1g

2-Azidoethanol 10% solution in Ethanol, 99.18%, 100g

5-Bromo-3-(N,N-dimethylaminocarbonyl)phenylboronic acid, 98%, 1g

Lithiumniobat-Pulver 99,9 % 50 g

2-(Allylsulfonyl)-3-methylpyridine>98.0%(GC)(N)1g

Ethyl 3-(2-(((4-(N-((heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (Dabigatran Impurity), 97%, 50mg

1-Tetradecene [Standard Material for GC]>99.5%(GC)5mL

4-(Bromomethyl)-2-methylthiazole hydrobromide, 97.0%, 1g

(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 250mg

TASIMELTEON, 95%, 10mg